Response by Petzold et al to Letter Regarding Article, "Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1"

Affiliations

• ¹ German Centre for Cardiovascular Research, Partner Site Munich Heart Alliance, Germany (T.P., M.T., J.P., A.E., E.L., L.N., T.J.S., C.S.).
• ² Medizinische Klinik und Poliklinik I, Klinikum der Universität München (T.P., M.T., Z.Z., R.R., J.P., A.E., E.L., L.N., T.J.S., J.S., I.S., C.S.), Ludwig-Maximilians-University, Munich, Germany.
• ³ From the Department of Cardiology, Pulmonology and Vascular Medicine (L.D., P.M., C.H., A. Ayhan, R.M., A. Achilles, K.T., C.J., N.G., T.Z., M.K., A.P.), Medical Faculty of the Heinrich Heine University Düsseldorf, Germany.
• ⁴ Cardiovascular Research Institute Düsseldorf, Germany (L.D., P.M., C.H., A. Ayhan, R.M., A. Achilles, K.T., C.J., N.G., T.Z., M.K., A.P.).
• ⁵ St. Mary's Square Institute for Vascular Surgery and Phlebology, Munich, Germany (R.B.).
• ⁶ German Heart Center, Institute for Laboratory Medicine, Technical University Munich (F.R.).
• ⁷ Department of Anesthesiology, Cell Therapeutics and Hemostaseology (M.S.), Ludwig-Maximilians-University, Munich, Germany.
• ⁸ Department of Transfusion Medicine, Cell Therapeutics and Hemostaseology (M.S.), Ludwig-Maximilians-University, Munich, Germany.
• ⁹ Helmholtz Zentrum München, Institute of Lung Biology and Disease, Group Systems Medicine of Chronic Lung Disease, Member of the German Center for Lung Research, Munich, Germany (C.H.M., H.B.S.).
• ¹⁰ Institute of Transplantation Diagnostics and Cell Therapeutics, Heinrich Heine University Medical Center Düsseldorf, Germany (T. Hoffmann).
• ¹¹ Institute of Pathophysiology, West German Heart and Vascular Center, University Hospital Essen, University of Duisburg-Essen, Germany (B.L.).
• ¹² Institute of Pharmacology and Clinical Pharmacology (T. Hohlfeld), Medical Faculty of the Heinrich Heine University Düsseldorf, Germany.